1. Home
  2. TROO vs AVIR Comparison

TROO vs AVIR Comparison

Compare TROO & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

N/A

Current Price

$1.91

Market Cap

151.5M

Sector

Technology

ML Signal

N/A

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$3.14

Market Cap

236.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROO
AVIR
Founded
2005
2012
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.5M
236.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TROO
AVIR
Price
$1.91
$3.14
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
91.7K
364.5K
Earning Date
12-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,084,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
247.24
N/A
52 Week Low
$0.49
$2.46
52 Week High
$2.62
$4.02

Technical Indicators

Market Signals
Indicator
TROO
AVIR
Relative Strength Index (RSI) 73.47 49.61
Support Level $1.76 $3.11
Resistance Level $1.75 $3.27
Average True Range (ATR) 0.21 0.10
MACD 0.05 0.01
Stochastic Oscillator 65.24 52.63

Price Performance

Historical Comparison
TROO
AVIR

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: